Healthtech Startups

iOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.

2 investors

Iona Mind develops low-intensity cognitive behavioral therapy (CBT) digital health products for behavioral and mental health management. The company specializes in customizable, evidence-based platforms that enable patients to access psychological support at their own pace with 24/7 care team support.

2 investors

A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.

2 investors

iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.

2 investors

Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.

2 investors

iQuartic provides an AI-driven platform that uses OCR, NLP, and machine learning to convert structured and unstructured medical records into machine-readable data and extract meaningful clinical information. Its tools support medical coding, risk adjustment, and analytics for healthcare organizations to identify coding and care gaps and predict patient-specific events.

2 investors

IQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

2 investors

Irazú Oncology develops cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform based on engineered bacterial nanoparticles that deliver cancer antigens. The biotech company, founded in 2022, is building a pipeline of immunotherapies for cancer patients.

2 investors

iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias. The platform combines engineered ECG monitors, machine learning algorithms, and expert clinical review to deliver actionable diagnostic reports.

2 investors

Iridex makes laser systems, EndoProbe handpieces, and vitreoretinal surgical consumables used for precision eye surgery in hospitals and ambulatory surgery centers. Its products serve ophthalmic surgeons in operating-room settings.

2 investors

Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.

2 investors

Iris Telehealth provides telepsychiatry and behavioral health services to health systems, hospitals, and community clinics through a medical group of psychiatrists, LCSWs, and PMHNPs. The Joint Commission-accredited company supports partner organizations in delivering psychiatric care across all ages, acuity levels, and diagnoses in the United States.

2 investors

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases. A NuXcel spinoff based in Minneapolis, it develops implantable neuromodulation therapies targeting large patient populations with unmet clinical needs.

2 investors

Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes. The company serves hospitals and emergency care settings in the United States, focusing on reducing cryptogenic strokes and enabling guideline-directed patient care.

2 investors

Isla is a health-tech company offering a digital pathway platform (DPP) that automates routine clinical admin and connects care workflows for NHS clinical teams. Founded in 2019 and based in London, it serves over 40 NHS Trusts with tools for media-led diagnostics and automated care pathways.

2 investors

ISOThrive is a clinical-stage biotech company developing proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis, aimed at treating chronic diseases linked to microbiome imbalance. Its lead asset, ISOT-101 (maltosyl-isomaltooligosaccharide/MIMO), is in a phase 2 study.

2 investors

ITH Group is a group of healthcare companies operating since 2008 that provides aseptic compounding, pharmacy dispensing, GP health center services, and digital health solutions. It serves patients and healthcare needs across its member companies, based in the UK.

2 investors

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.

2 investors

J2 Health provides a software platform for health plans to manage provider network adequacy, benchmark network competitiveness, and automate provider outreach and data collection. It supports CMS, state, employer, and NCQA regulatory requirements for healthcare organizations in the United States.

2 investors

Jade Biosciences develops therapeutic antibodies targeting autoimmune diseases, with a lead candidate in clinical development for immunoglobulin A nephropathy, a chronic kidney disease. The company's pipeline includes additional candidates designed to modulate immune system responses in autoimmune conditions.

2 investors

Jaide Health provides AI-powered real-time interpretation and translation services for healthcare organizations to communicate with limited English proficiency (LEP) patients across clinical and administrative interactions. The platform uses HIPAA-compliant AI to reduce costs and improve access to care.

2 investors

Ruma provides prior authorization software for healthcare practices, helping clinics manage and scale authorization requests across multiple locations. The platform serves medical and pharmacy benefit authorizations for healthcare providers.

2 investors

Jellyvision creates custom digital communication tools and content—such as videos and interactive experiences—to help employers raise employee awareness and engagement with their benefits programs. It serves HR and benefits teams, addressing challenges like retiree benefits, mental health, parental leave, and pay transparency.

2 investors

Jelt distributes and manufactures clinical and hospital furniture, medical textiles, biosecurity products, and medical devices for healthcare facilities in Colombia. The company sells directly to clinics, hospitals, and healthcare providers through an e-commerce platform.

2 investors